SEROXAT

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Finland, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Malta, Netherlands, Poland, Romania, Singapore, Spain, UK.

Active ingredients

The drug SEROXAT contains one active pharmaceutical ingredient (API):

1	Paroxetine UNII 3I3T11UD2S - PAROXETINE HYDROCHLORIDE ANHYDROUS
	Paroxetine is a potent and selective inhibitor of 5-hydroxytryptamine (5-HT, serotonin) uptake and its antidepressant action and effectiveness in the treatment of OCD, Social Anxiety disorder/Social Phobia, General Anxiety Disorder, Post-Traumatic Stress Disorder and Panic Disorder is thought to be related to its specific inhibition of 5-HT uptake in brain neurones.
	Read more about Paroxetine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SEROXAT Film-coated tablet / Oral suspension	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AB05	Paroxetine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors
Discover more medicines within N06AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00191690, 00191709, 00221221, 00614475, 00614481, 00614498, 10273093, 11229473
EE	Ravimiamet	1027044, 1060221, 1060232, 1060243, 1304334, 1855054, 1855144, 1855155
ES	Centro de información online de medicamentos de la AEMPS	59468
FI	Lääkealan turvallisuus- ja kehittämiskeskus	038257, 038448
GB	Medicines & Healthcare Products Regulatory Agency	112707, 140011, 162434, 162436, 162438, 175954, 186127, 19311, 19312, 21579, 375966
HK	Department of Health Drug Office	51959, 51960, 64700
HR	Agencija za lijekove i medicinske proizvode	HR-H-051250245, HR-H-284734421
IE	Health Products Regulatory Authority	45206, 45241, 45268, 45285, 45601, 45608, 45609, 45691
IL	מִשְׂרַד הַבְּרִיאוּת	2892
IT	Agenzia del Farmaco	027963038
LT	Valstybinė vaistų kontrolės tarnyba	1003159, 1003732, 1021137, 1023776, 1023777, 1023778, 1023779, 1023780, 1023781, 1023782, 1023783, 1023784, 1023785, 1023786, 1023806, 1023808, 1023809, 1024257, 1024258, 1034677, 1057990, 1057991, 1057992, 1057993, 1057994, 1057995, 1057996, 1057997, 1057998, 1057999, 1058000, 1058001, 1058002, 1058003, 1058004, 1058005, 1058006, 1058007, 1082801
MT	Medicines Authority	MA192/02501, PI908/01101A
NL	Z-Index G-Standaard	14558785
NL	Z-Index G-Standaard, PRK	125032, 125059, 56154
PL	Rejestru Produktów Leczniczych	100060832, 100255961, 100283779, 100285689, 100333543, 100360570, 100366778, 100370461, 100377115, 100399460, 100424961, 100431903, 100460562
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65203001, W65203003
SG	Health Sciences Authority	07053P, 12583P, 12584P